Abstract
Schizophrenia is a condition that has burdensome and long-lasting costs in terms of suffering and economic drain on patients, families, and society. In many countries the need of allocating economic and human resources to therapeutic and management modalities on a cost-effective basis seems to suggest the relevance of an interdisciplinary collaboration between psychiatrists and economists.